Clinical Trial Update: Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that TQB3201 tablets are being evaluated for tolerability in metastatic castration-resistant prostate cancer in Phase 1 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• TQB3201 tablets (TQB3201)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING